SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001601830-23-000058
Filing Date
2023-08-08
Accepted
2023-08-08 08:11:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS [RULE 424(B)(7)] rxrx-prospectussupplement2.htm 424B7 556580
2 EX-FILING FEES exhibit107-nvidiafeetable.htm EX-FILING FEES 27898
3 image_0a.jpg GRAPHIC 13223
4 image_1.jpg GRAPHIC 3981
  Complete submission text file 0001601830-23-000058.txt   609471
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-264845 | Film No.: 231149430
SIC: 2836 Biological Products, (No Diagnostic Substances)